ALT Annual Total Long Term Liabilities
$4.40 M
-$183.00 K-3.99%
31 December 2023
Summary:
As of January 23, 2025, ALT annual total long term liabilities is $4.40 million, with the most recent change of -$183.00 thousand (-3.99%) on December 31, 2023. During the last 3 years, it has fallen by -$2.82 million (-39.07%). ALT annual total long term liabilities is now -76.50% below its all-time high of $18.71 million, reached on December 31, 2009.ALT Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ALT Quarterly Long Term Liabilities
$5.85 M
+$189.00 K+3.34%
30 September 2024
Summary:
As of January 23, 2025, ALT quarterly total long term liabilities is $5.85 million, with the most recent change of +$189.00 thousand (+3.34%) on September 30, 2024. Over the past year, it has increased by +$1.45 million (+32.99%). ALT quarterly long term liabilities is now -78.33% below its all-time high of $27.00 million, reached on September 30, 2020.ALT Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ALT Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -4.0% | +33.0% |
| 3 y3 years | -39.1% | -31.3% |
| 5 y5 years | +130.2% | +28.9% |
ALT Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -4.0% | +202.5% | at high | +302.3% |
| 5 y | 5-year | -39.1% | +202.5% | -78.3% | +302.3% |
| alltime | all time | -76.5% | +508.9% | -78.3% | +1321.0% |
Altimmune Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $5.85 M(+3.3%) |
| June 2024 | - | $5.66 M(+38.5%) |
| Mar 2024 | - | $4.09 M(-7.0%) |
| Dec 2023 | $4.40 M(-4.0%) | $4.40 M(+2.2%) |
| Sept 2023 | - | $4.30 M(+3.4%) |
| June 2023 | - | $4.17 M(-5.3%) |
| Mar 2023 | - | $4.40 M(-4.0%) |
| Dec 2022 | $4.58 M(+215.1%) | $4.58 M(+1.7%) |
| Sept 2022 | - | $4.51 M(+195.3%) |
| June 2022 | - | $1.53 M(-8.5%) |
| Mar 2022 | - | $1.67 M(+14.7%) |
| Dec 2021 | $1.45 M(-79.9%) | $1.45 M(-82.9%) |
| Sept 2021 | - | $8.52 M(+23.6%) |
| June 2021 | - | $6.89 M(-13.8%) |
| Mar 2021 | - | $7.99 M(+10.7%) |
| Dec 2020 | $7.22 M(+56.4%) | $7.22 M(-73.3%) |
| Sept 2020 | - | $27.00 M(+49.1%) |
| June 2020 | - | $18.11 M(+187.8%) |
| Mar 2020 | - | $6.29 M(+36.3%) |
| Dec 2019 | $4.61 M(+141.5%) | $4.61 M(+1.7%) |
| Sept 2019 | - | $4.54 M(+99.8%) |
| June 2019 | - | $2.27 M(-4.4%) |
| Mar 2019 | - | $2.38 M(+24.3%) |
| Dec 2018 | $1.91 M(-81.8%) | $1.91 M(-60.5%) |
| Sept 2018 | - | $4.83 M(-44.5%) |
| June 2018 | - | $8.72 M(-5.4%) |
| Mar 2018 | - | $9.22 M(-12.3%) |
| Dec 2017 | $10.51 M(+1355.5%) | $10.51 M(-19.7%) |
| Sept 2017 | - | $13.10 M(+40.3%) |
| June 2017 | - | $9.34 M(+2009.7%) |
| Mar 2017 | - | $442.60 K(-38.7%) |
| Dec 2016 | $722.30 K(-30.1%) | $722.30 K(+69.1%) |
| Sept 2016 | - | $427.10 K(+3.8%) |
| June 2016 | - | $411.60 K(-12.1%) |
| Mar 2016 | - | $468.00 K(-54.7%) |
| Dec 2015 | $1.03 M | $1.03 M(+22.6%) |
| Sept 2015 | - | $842.90 K(-10.7%) |
| June 2015 | - | $944.40 K(+4.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2015 | - | $905.30 K(-19.3%) |
| Dec 2014 | $1.12 M(-62.7%) | $1.12 M(-17.4%) |
| Sept 2014 | - | $1.36 M(-11.0%) |
| June 2014 | - | $1.53 M(-40.9%) |
| Mar 2014 | - | $2.58 M(-14.1%) |
| Dec 2013 | $3.01 M(-16.0%) | $3.01 M(-21.9%) |
| Sept 2013 | - | $3.85 M(+5.7%) |
| June 2013 | - | $3.64 M(-14.1%) |
| Mar 2013 | - | $4.24 M(+18.5%) |
| Dec 2012 | $3.58 M(+53.2%) | $3.58 M(-8.0%) |
| Sept 2012 | - | $3.89 M(-15.5%) |
| June 2012 | - | $4.60 M(-18.8%) |
| Mar 2012 | - | $5.67 M(+142.6%) |
| Dec 2011 | $2.34 M(-73.5%) | $2.34 M(-31.5%) |
| Sept 2011 | - | $3.41 M(-46.0%) |
| June 2011 | - | $6.31 M(-0.4%) |
| Mar 2011 | - | $6.34 M(-28.2%) |
| Dec 2010 | $8.82 M(-52.8%) | $8.82 M(+195.2%) |
| Sept 2010 | - | $2.99 M(-85.6%) |
| June 2010 | - | $20.77 M(+7.6%) |
| Mar 2010 | - | $19.31 M(+3.2%) |
| Dec 2009 | $18.71 M(+1103.7%) | $18.71 M(-2.3%) |
| Sept 2009 | - | $19.15 M(+1200.6%) |
| June 2009 | - | $1.47 M(-56.5%) |
| Mar 2009 | - | $3.39 M(+118.0%) |
| Dec 2008 | $1.55 M(-90.9%) | $1.55 M(-84.0%) |
| Sept 2008 | - | $9.70 M(-58.9%) |
| June 2008 | - | $23.61 M(+44.2%) |
| Mar 2008 | - | $16.37 M(-3.9%) |
| Dec 2007 | $17.04 M(+603.2%) | $17.04 M(-3.6%) |
| Sept 2007 | - | $17.68 M(+30.2%) |
| Mar 2007 | - | $13.58 M(+460.3%) |
| Dec 2006 | $2.42 M(-82.2%) | $2.42 M(-82.2%) |
| Sept 2006 | - | $13.58 M(0.0%) |
| June 2006 | - | $13.58 M(0.0%) |
| Mar 2006 | - | $13.58 M(0.0%) |
| Dec 2005 | $13.58 M | $13.58 M(0.0%) |
| Sept 2005 | - | $13.58 M |
FAQ
- What is Altimmune annual total long term liabilities?
- What is the all time high annual total long term liabilities for Altimmune?
- What is Altimmune annual total long term liabilities year-on-year change?
- What is Altimmune quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Altimmune?
- What is Altimmune quarterly long term liabilities year-on-year change?
What is Altimmune annual total long term liabilities?
The current annual total long term liabilities of ALT is $4.40 M
What is the all time high annual total long term liabilities for Altimmune?
Altimmune all-time high annual total long term liabilities is $18.71 M
What is Altimmune annual total long term liabilities year-on-year change?
Over the past year, ALT annual total long term liabilities has changed by -$183.00 K (-3.99%)
What is Altimmune quarterly total long term liabilities?
The current quarterly long term liabilities of ALT is $5.85 M
What is the all time high quarterly long term liabilities for Altimmune?
Altimmune all-time high quarterly total long term liabilities is $27.00 M
What is Altimmune quarterly long term liabilities year-on-year change?
Over the past year, ALT quarterly total long term liabilities has changed by +$1.45 M (+32.99%)